2021 Q4 Form 10-K Financial Statement

#000082922421000086 Filed on November 19, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q3
Revenue $8.147B $29.06B $6.203B
YoY Change 20.7% 23.57% -8.06%
Cost Of Revenue $5.765B $20.63B $4.660B
YoY Change 17.25% 12.1% -4.67%
Gross Profit $2.382B $8.435B $1.543B
YoY Change 29.96% 64.79% -16.98%
Gross Profit Margin 29.24% 29.03% 24.88%
Selling, General & Admin $501.2M $1.933B $439.0M
YoY Change 6.16% 15.04% 8.42%
% of Gross Profit 21.04% 22.91% 28.45%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $377.9M $1.524B $379.0M
YoY Change -2.7% 1.39% 3.84%
% of Gross Profit 15.86% 18.07% 24.56%
Operating Expenses $964.6M $3.734B $902.0M
YoY Change 3.72% 5.42% 5.44%
Operating Profit $1.418B $4.872B $558.3M
YoY Change 55.18% 211.97% -48.46%
Interest Expense $20.90M $469.8M -$3.700M
YoY Change -82.68% 7.51% -129.6%
% of Operating Profit 1.47% 9.64% -0.66%
Other Income/Expense, Net
YoY Change
Pretax Income $2.248B $5.357B $442.4M
YoY Change 178.07% 360.06% -55.93%
Income Tax $483.0M $1.157B $49.70M
% Of Pretax Income 21.49% 21.59% 11.23%
Net Earnings $1.764B $4.199B $392.6M
YoY Change 183.57% 352.36% -51.1%
Net Earnings / Revenue 21.66% 14.45% 6.33%
Basic Earnings Per Share $3.57
Diluted Earnings Per Share $1.485M $3.54 $0.33
COMMON SHARES
Basic Shares Outstanding 1.173B shares 1.178B shares 1.169B shares
Diluted Shares Outstanding 1.186B shares

Balance Sheet

Concept 2021 Q4 2021 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.618B $6.618B $4.632B
YoY Change 25.72% 42.87% 68.01%
Cash & Equivalents $6.456B $6.456B $4.351B
Short-Term Investments $162.2M $162.2M $281.0M
Other Short-Term Assets $401.5M $401.5M $228.0M
YoY Change 58.7% 76.1% -34.48%
Inventory $1.604B $1.604B $1.551B
Prepaid Expenses
Receivables $940.0M $940.0M $883.4M
Other Receivables $193.1M $193.1M $512.0M
Total Short-Term Assets $9.756B $9.756B $7.806B
YoY Change 16.74% 24.99% 38.07%
LONG-TERM ASSETS
Property, Plant & Equipment $6.370B $14.61B $6.241B
YoY Change 3.1% 1.6% -2.96%
Goodwill $3.677B $3.597B
YoY Change -0.8% 3.05%
Intangibles $349.9M $552.1M
YoY Change -30.9% -29.38%
Long-Term Investments $216.0M $550.2M $426.4M
YoY Change -68.56% -19.68% 26.87%
Other Assets $578.5M $2.453B $568.6M
YoY Change 6.91% 4.0% 18.56%
Total Long-Term Assets $21.64B $21.64B $21.57B
YoY Change 0.12% 0.31% 58.99%
TOTAL ASSETS
Total Short-Term Assets $9.756B $9.756B $7.806B
Total Long-Term Assets $21.64B $21.64B $21.57B
Total Assets $31.39B $31.39B $29.37B
YoY Change 4.75% 6.87% 52.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.212B $1.212B $997.9M
YoY Change 15.32% 21.4% -16.12%
Accrued Expenses $2.321B $2.971B $1.161B
YoY Change 43.56% 10.09% -33.81%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $438.8M
YoY Change -100.0% -100.0%
Long-Term Debt Due $998.9M $998.9M $1.250B
YoY Change 33.19% -20.09%
Total Short-Term Liabilities $8.151B $8.151B $7.347B
YoY Change 3.39% 10.95% 19.1%
LONG-TERM LIABILITIES
Long-Term Debt $13.62B $13.62B $14.66B
YoY Change -7.2% -7.12% 31.28%
Other Long-Term Liabilities $14.79B $14.79B $15.01B
YoY Change -3.43% -1.46% 89.36%
Total Long-Term Liabilities $13.62B $28.41B $14.66B
YoY Change -7.2% -4.25% 31.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.151B $8.151B $7.347B
Total Long-Term Liabilities $13.62B $28.41B $14.66B
Total Liabilities $36.71B $36.71B $37.17B
YoY Change -3.08% -1.25% 46.06%
SHAREHOLDERS EQUITY
Retained Earnings -$6.316B -$7.816B
YoY Change -23.48% 35.42%
Common Stock $847.3M $375.1M
YoY Change 72.99% 786.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.321B -$5.321B -$7.805B
YoY Change
Total Liabilities & Shareholders Equity $31.39B $31.39B $29.37B
YoY Change 4.75% 6.87% 52.84%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q3
OPERATING ACTIVITIES
Net Income $1.764B $4.199B $392.6M
YoY Change 183.57% 352.36% -51.1%
Depreciation, Depletion And Amortization $377.9M $1.524B $379.0M
YoY Change -2.7% 1.39% 3.84%
Cash From Operating Activities $1.521B $5.989B $1.491B
YoY Change -17.16% 274.83% 34.57%
INVESTING ACTIVITIES
Capital Expenditures -$484.3M $1.470B -$346.0M
YoY Change -249.38% -0.92% -34.22%
Acquisitions
YoY Change
Other Investing Activities $1.151B $81.20M -$35.00M
YoY Change 6402.82% 82.88% -259.09%
Cash From Investing Activities $666.7M -$319.5M -$380.0M
YoY Change -344.66% -81.33% -24.6%
FINANCING ACTIVITIES
Cash Dividend Paid $2.119B
YoY Change 10.16%
Common Stock Issuance & Retirement, Net -$246.2M
YoY Change -117.58%
Debt Paid & Issued, Net $1.250B
YoY Change
Cash From Financing Activities -483.1M -$3.651B -780.0M
YoY Change -49.98% -313.1% -70.39%
NET CHANGE
Cash From Operating Activities 1.521B $5.989B 1.491B
Cash From Investing Activities 666.7M -$319.5M -380.0M
Cash From Financing Activities -483.1M -$3.651B -780.0M
Net Change In Cash 1.704B $2.019B 331.0M
YoY Change 185.29% 26.19% -116.31%
FREE CASH FLOW
Cash From Operating Activities $1.521B $5.989B $1.491B
Capital Expenditures -$484.3M $1.470B -$346.0M
Free Cash Flow $2.005B $4.519B $1.837B
YoY Change 32.65% 3857.18% 12.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-03
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0000829224
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2400000000 shares
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2400000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1180000000 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1173300000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1180000000 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1173300000 shares
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-10-03
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
0-20322
CY2021 dei Entity Registrant Name
EntityRegistrantName
Starbucks Corporation
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WA
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-1325671
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
2401 Utah Avenue South
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Seattle
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98134
CY2021 dei City Area Code
CityAreaCode
206
CY2021 dei Local Phone Number
LocalPhoneNumber
447-1575
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
CY2021 dei Trading Symbol
TradingSymbol
SBUX
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021Q1 dei Entity Public Float
EntityPublicFloat
129300000000 USD
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1173200000 shares
CY2021 us-gaap Revenues
Revenues
29060600000 USD
CY2020 us-gaap Revenues
Revenues
23518000000 USD
CY2019 us-gaap Revenues
Revenues
26508600000 USD
CY2021 us-gaap Production And Distribution Costs
ProductionAndDistributionCosts
8738700000 USD
CY2020 us-gaap Production And Distribution Costs
ProductionAndDistributionCosts
7694900000 USD
CY2019 us-gaap Production And Distribution Costs
ProductionAndDistributionCosts
8526900000 USD
CY2021 sbux Store Operating Expenses
StoreOperatingExpenses
11930900000 USD
CY2020 sbux Store Operating Expenses
StoreOperatingExpenses
10764000000 USD
CY2019 sbux Store Operating Expenses
StoreOperatingExpenses
10493600000 USD
CY2021 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
359500000 USD
CY2020 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
430300000 USD
CY2019 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
371000000.0 USD
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1441700000 USD
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1431300000 USD
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1377300000 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1932600000 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1679600000 USD
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1824100000 USD
CY2021 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
170400000 USD
CY2020 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
278700000 USD
CY2019 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
135800000 USD
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
24573800000 USD
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
22278800000 USD
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
22728700000 USD
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
385300000 USD
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
322500000 USD
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
298000000.0 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
4872100000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
1561700000 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
4077900000 USD
CY2021 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
864500000 USD
CY2020 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2019 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
622800000 USD
CY2021 us-gaap Interest And Other Income
InterestAndOtherIncome
90100000 USD
CY2020 us-gaap Interest And Other Income
InterestAndOtherIncome
39700000 USD
CY2019 us-gaap Interest And Other Income
InterestAndOtherIncome
96500000 USD
CY2021 us-gaap Interest Expense
InterestExpense
469800000 USD
CY2020 us-gaap Interest Expense
InterestExpense
437000000.0 USD
CY2019 us-gaap Interest Expense
InterestExpense
331000000.0 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5356900000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1164400000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4466200000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1156600000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
239700000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
871600000 USD
CY2021 us-gaap Profit Loss
ProfitLoss
4200300000 USD
CY2020 us-gaap Profit Loss
ProfitLoss
924700000 USD
CY2019 us-gaap Profit Loss
ProfitLoss
3594600000 USD
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000.0 USD
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3600000 USD
CY2019 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4600000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
4199300000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
928300000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
3599200000 USD
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.57
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.79
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.95
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.54
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.79
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.92
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1177600000 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1172800000 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1221200000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1185500000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1181800000 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1233200000 shares
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1495400000 USD
CY2021 sbux Income Lossfrom Equity Method Investments1
IncomeLossfromEquityMethodInvestments1
347300000 USD
CY2021 us-gaap Profit Loss
ProfitLoss
4200300000 USD
CY2020 us-gaap Profit Loss
ProfitLoss
924700000 USD
CY2019 us-gaap Profit Loss
ProfitLoss
3594600000 USD
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
511800000 USD
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
133900000 USD
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-173000000.0 USD
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
4712100000 USD
CY2020 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1058600000 USD
CY2019 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
3421600000 USD
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4711100000 USD
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1062200000 USD
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3426200000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6455700000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4350900000 USD
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
162200000 USD
CY2020Q3 us-gaap Short Term Investments
ShortTermInvestments
281200000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
940000000.0 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
883400000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
1603900000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
1551400000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
594600000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
739500000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
9756400000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
7806400000 USD
CY2021Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
281700000 USD
CY2020Q3 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
206100000 USD
CY2021Q4 sbux Equity Investments
EquityInvestments
268500000 USD
CY2020Q3 sbux Equity Investments
EquityInvestments
478700000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6369500000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6241400000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8236000000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8134100000 USD
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
1874800000 USD
CY2020Q3 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
1789900000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
578500000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
568600000 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
349900000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
552100000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
3677300000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
3597200000 USD
CY2021Q4 us-gaap Assets
Assets
31392600000 USD
CY2020Q3 us-gaap Assets
Assets
29374500000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1211600000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
997900000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1973200000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1160700000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
772300000 USD
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
696000000.0 USD
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
348000000.0 USD
CY2020Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
98200000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1251300000 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1248800000 USD
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1596100000 USD
CY2020Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1456500000 USD
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
0 USD
CY2020Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
438800000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
998900000 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1249900000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8151400000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7346800000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
13616900000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
14659600000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7738000000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7661700000 USD
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
6463000000 USD
CY2020Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
6598500000 USD
CY2021Q4 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
737800000 USD
CY2020Q3 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
907300000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
36707100000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
37173900000 USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2400000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1180000000 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1173300000 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1200000 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
1200000 USD
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
846100000 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
373900000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6315700000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7815600000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
147200000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-364600000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-5321200000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-7805100000 USD
CY2021Q4 us-gaap Minority Interest
MinorityInterest
6700000 USD
CY2020Q3 us-gaap Minority Interest
MinorityInterest
5700000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-5314500000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-7799400000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31392600000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29374500000 USD
CY2021 us-gaap Profit Loss
ProfitLoss
4200300000 USD
CY2020 us-gaap Profit Loss
ProfitLoss
924700000 USD
CY2019 us-gaap Profit Loss
ProfitLoss
3594600000 USD
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1524100000 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1503200000 USD
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1449300000 USD
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-146200000 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-25800000 USD
CY2020 sbux Income Lossfrom Equity Method Investments1
IncomeLossfromEquityMethodInvestments1
280700000 USD
CY2019 sbux Income Lossfrom Equity Method Investments1
IncomeLossfromEquityMethodInvestments1
250600000 USD
CY2021 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
336000000.0 USD
CY2020 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
227700000 USD
CY2019 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
216800000 USD
CY2021 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
864500000 USD
CY2020 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2019 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
622800000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
319100000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
248600000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
308000000.0 USD
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
10500000 USD
CY2021 sbux Non Cash Lease Expense
NonCashLeaseExpense
1248600000 USD
CY2020 sbux Non Cash Lease Expense
NonCashLeaseExpense
1197600000 USD
CY2019 sbux Non Cash Lease Expense
NonCashLeaseExpense
0 USD
CY2021 sbux Loss On Retirement And Impairment Of Assets
LossOnRetirementAndImpairmentOfAssets
226200000 USD
CY2020 sbux Loss On Retirement And Impairment Of Assets
LossOnRetirementAndImpairmentOfAssets
454400000 USD
CY2019 sbux Loss On Retirement And Impairment Of Assets
LossOnRetirementAndImpairmentOfAssets
142600000 USD
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-6000000.0 USD
CY2020 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
24500000 USD
CY2019 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
45300000 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
43000000.0 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2700000 USD
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
197700000 USD
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
49800000 USD
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10900000 USD
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
173000000.0 USD
CY2021 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-251100000 USD
CY2020 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-317500000 USD
CY2019 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
922000000.0 USD
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
286100000 USD
CY2020 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1214600000 USD
CY2019 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1237100000 USD
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
189900000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-210800000 USD
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
31900000 USD
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-6100000 USD
CY2020 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
31000000.0 USD
CY2019 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-30500000 USD
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1488100000 USD
CY2020 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1231400000 USD
CY2019 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 USD
CY2021 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-358700000 USD
CY2020 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-280500000 USD
CY2019 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
141100000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5989100000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1597800000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5047000000 USD
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
432000000.0 USD
CY2020 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
443900000 USD
CY2019 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
190400000 USD
CY2021 sbux Proceedsfrom Salesof Investments
ProceedsfromSalesofInvestments
143200000 USD
CY2020 sbux Proceedsfrom Salesof Investments
ProceedsfromSalesofInvestments
186700000 USD
CY2019 sbux Proceedsfrom Salesof Investments
ProceedsfromSalesofInvestments
298300000 USD
CY2021 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
345500000 USD
CY2020 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
73700000 USD
CY2019 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
59800000 USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1470000000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1483600000 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1806600000 USD
CY2021 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
1175000000 USD
CY2020 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
0 USD
CY2019 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
684300000 USD
CY2021 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
81200000 USD
CY2020 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
44400000 USD
CY2019 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
56200000 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-319500000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1711500000 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1010800000 USD
CY2021 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
-296500000 USD
CY2020 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
0 USD
CY2019 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
0 USD
CY2021 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
215100000 USD
CY2020 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
1406600000 USD
CY2019 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 USD
CY2021 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
349800000 USD
CY2020 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
967700000 USD
CY2019 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 USD
CY2021 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2020 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
4727600000 USD
CY2019 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1996000000 USD
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1250000000 USD
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2019 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
350000000.0 USD
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
246200000 USD
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
298800000 USD
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
409800000 USD
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
2119000000 USD
CY2020 us-gaap Payments Of Dividends
PaymentsOfDividends
1923500000 USD
CY2019 us-gaap Payments Of Dividends
PaymentsOfDividends
1761300000 USD
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1698900000 USD
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
10222300000 USD
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
97000000.0 USD
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
91900000 USD
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
111600000 USD
CY2021 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
CY2020 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-37700000 USD
CY2019 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-17500000 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3651000000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1713300000 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10056900000 USD
CY2021 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
86200000 USD
CY2020 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
64700000 USD
CY2019 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-49000000.0 USD
CY2021 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2104800000 USD
CY2020 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1664300000 USD
CY2019 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6069700000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4350900000 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2686600000 USD
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8756300000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6455700000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4350900000 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2686600000 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
501100000 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
396900000 USD
CY2019 us-gaap Interest Paid Net
InterestPaidNet
299500000 USD
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
756300000 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1699100000 USD
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
470100000 USD
CY2018Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1175800000 USD
CY2019Q3 sbux Cumulative Effect Of New Accounting Pronouncement In Period Of Adoption
CumulativeEffectOfNewAccountingPronouncementInPeriodOfAdoption
495600000 USD
CY2019 us-gaap Profit Loss
ProfitLoss
3594600000 USD
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-173000000.0 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
311300000 USD
CY2019 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
264900000 USD
CY2019 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
33400000 USD
CY2019 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-10131500000 USD
CY2019 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.49
CY2019 us-gaap Dividends Cash
DividendsCash
1801600000 USD
CY2019 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
500000 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-6231000000 USD
CY2020Q3 sbux Cumulative Effect Of New Accounting Pronouncement In Period Of Adoption
CumulativeEffectOfNewAccountingPronouncementInPeriodOfAdoption
17300000 USD
CY2020 us-gaap Profit Loss
ProfitLoss
924700000 USD
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
133900000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
252100000 USD
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
169900000 USD
CY2020 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
37200000 USD
CY2020 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-1675000000 USD
CY2020 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.23
CY2020 us-gaap Dividends Cash
DividendsCash
1436800000 USD
CY2020 us-gaap Noncontrolling Interest Increase From Sale Of Parent Equity Interest
NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
8300000 USD
CY2020 sbux Net Disposition And Impairment Charges
NetDispositionAndImpairmentCharges
294900000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-7799400000 USD
CY2021Q4 sbux Cumulative Effect Of New Accounting Pronouncement In Period Of Adoption
CumulativeEffectOfNewAccountingPronouncementInPeriodOfAdoption
-2200000 USD
CY2021 us-gaap Profit Loss
ProfitLoss
4200300000 USD
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
511800000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
322800000 USD
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
107000000.0 USD
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
42400000 USD
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.29
CY2021 us-gaap Dividends Cash
DividendsCash
2697200000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-5314500000 USD
CY2021 us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year End</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year ends on the Sunday closest to September 30. Fiscal year 2021 included 53 weeks, with the 53rd week falling in the fourth fiscal quarter. Fiscal years 2020 and 2019 included 52 weeks.</span></div>
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimates and Assumptions</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparing financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Examples include, but are not limited to, estimates for inventory reserves, asset and goodwill impairments, assumptions underlying self-insurance reserves, income from unredeemed stored value cards, stock-based compensation forfeiture rates, future asset retirement obligations and the potential outcome of future tax consequences of events that have been recognized in the financial statements. Actual results and outcomes may differ from these estimates and assumptions due to risks and uncertainties, including uncertainty in the current economic environment due to the global COVID-19 pandemic.</span></div>
CY2021 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
155400000 USD
CY2020 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
254700000 USD
CY2021Q4 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
44700000 USD
CY2020Q3 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
34900000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
25600000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
27100000 USD
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
36600000 USD
CY2020Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
48400000 USD
CY2021 sbux Net Disposition And Impairment Charges
NetDispositionAndImpairmentCharges
153100000 USD
CY2019 sbux Net Disposition And Impairment Charges
NetDispositionAndImpairmentCharges
108000000 USD
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
10500000 USD
CY2021 us-gaap Advertising Expense
AdvertisingExpense
305100000 USD
CY2020 us-gaap Advertising Expense
AdvertisingExpense
258800000 USD
CY2019 us-gaap Advertising Expense
AdvertisingExpense
245700000 USD
CY2021 sbux Payroll Tax Incentives
PayrollTaxIncentives
210000000 USD
CY2020 sbux Payroll Tax Incentives
PayrollTaxIncentives
349600000 USD
CY2021Q4 us-gaap Other Receivables
OtherReceivables
172400000 USD
CY2020Q3 us-gaap Other Receivables
OtherReceivables
155100000 USD
CY2021 sbux Deferred Payroll Tax Payments
DeferredPayrollTaxPayments
81700000 USD
CY2021Q4 sbux Deferred Payroll Tax Payments Current
DeferredPayrollTaxPaymentsCurrent
116400000 USD
CY2021Q4 sbux Deferred Payroll Tax Payments Noncurrent
DeferredPayrollTaxPaymentsNoncurrent
116400000 USD
CY2020Q3 sbux Deferred Payroll Tax Payments Noncurrent
DeferredPayrollTaxPaymentsNoncurrent
151000000 USD
CY2021Q4 us-gaap Capitalized Costs Asset Retirement Costs
CapitalizedCostsAssetRetirementCosts
30900000 USD
CY2020Q3 us-gaap Capitalized Costs Asset Retirement Costs
CapitalizedCostsAssetRetirementCosts
30700000 USD
CY2021Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
116500000 USD
CY2020Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
111000000 USD
us-gaap Proceeds From Divestiture Of Interest In Joint Venture
ProceedsFromDivestitureOfInterestInJointVenture
1175000000 USD
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
7131500000 USD
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
16800000 USD
CY2020Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
4941100000 USD
CY2020Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
86600000 USD
CY2021 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
134100000 USD
CY2020 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
177400000 USD
CY2019 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
291100000 USD
CY2021Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
105200000 USD
CY2020Q3 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
91400000 USD
CY2021Q4 sbux Unroasted Coffee Inventory
UnroastedCoffeeInventory
670300000 USD
CY2020Q3 sbux Unroasted Coffee Inventory
UnroastedCoffeeInventory
664700000 USD
CY2021Q4 sbux Roasted Coffee Inventory
RoastedCoffeeInventory
233500000 USD
CY2020Q3 sbux Roasted Coffee Inventory
RoastedCoffeeInventory
223500000 USD
CY2021Q4 us-gaap Retail Related Inventory Merchandise
RetailRelatedInventoryMerchandise
329300000 USD
CY2020Q3 us-gaap Retail Related Inventory Merchandise
RetailRelatedInventoryMerchandise
293900000 USD
CY2021Q4 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
370800000 USD
CY2020Q3 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
369300000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
1603900000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
1551400000 USD
CY2020Q1 us-gaap Inventory Write Down
InventoryWriteDown
50000000 USD
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
216000000.0 USD
CY2020Q3 us-gaap Equity Method Investments
EquityMethodInvestments
426400000 USD
CY2021Q4 us-gaap Other Investments
OtherInvestments
52500000 USD
CY2020Q3 us-gaap Other Investments
OtherInvestments
52300000 USD
CY2021Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures Fair Value Disclosure
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure
268500000 USD
CY2020Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures Fair Value Disclosure
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure
478700000 USD
CY2021 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
160800000 USD
CY2020 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
123900000 USD
CY2019 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
130700000 USD
CY2021 sbux Related Parties Amount In Product And Distribution Costs
RelatedPartiesAmountInProductAndDistributionCosts
92100000 USD
CY2020 sbux Related Parties Amount In Product And Distribution Costs
RelatedPartiesAmountInProductAndDistributionCosts
79800000 USD
CY2019 sbux Related Parties Amount In Product And Distribution Costs
RelatedPartiesAmountInProductAndDistributionCosts
73200000 USD
CY2021Q4 us-gaap Due From Affiliate Current
DueFromAffiliateCurrent
7900000 USD
CY2020Q3 us-gaap Due From Affiliate Current
DueFromAffiliateCurrent
28700000 USD
CY2020 sbux Store Operating Expenses
StoreOperatingExpenses
10764000000 USD
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
20700000 USD
CY2020Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
356900000 USD
CY2021Q4 us-gaap Other Receivables
OtherReceivables
172400000 USD
CY2020Q3 us-gaap Other Receivables
OtherReceivables
155100000 USD
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
401500000 USD
CY2020Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
227500000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
594600000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
739500000 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14828800000 USD
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14155300000 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8459300000 USD
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7913900000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6369500000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6241400000 USD
CY2021Q4 sbux Accrued Occupancy Costs
AccruedOccupancyCosts
107100000 USD
CY2020Q3 sbux Accrued Occupancy Costs
AccruedOccupancyCosts
76900000 USD
CY2021Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
578100000 USD
CY2020Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
0 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
840700000 USD
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
677200000 USD
CY2021Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
229300000 USD
CY2020Q3 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
243900000 USD
CY2021Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
218000000.0 USD
CY2020Q3 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
162700000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1973200000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1160700000 USD
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6989300000 USD
CY2020 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6131900000 USD
CY2019 us-gaap Labor And Related Expense
LaborAndRelatedExpense
5941700000 USD
CY2021 sbux Store Occupancy Cost
StoreOccupancyCost
2561500000 USD
CY2020 sbux Store Occupancy Cost
StoreOccupancyCost
2388000000 USD
CY2019 sbux Store Occupancy Cost
StoreOccupancyCost
2411200000 USD
CY2021 sbux Other Store Operating Expenses
OtherStoreOperatingExpenses
2380100000 USD
CY2020 sbux Other Store Operating Expenses
OtherStoreOperatingExpenses
2244100000 USD
CY2019 sbux Other Store Operating Expenses
OtherStoreOperatingExpenses
2140700000 USD
CY2021 sbux Store Operating Expenses
StoreOperatingExpenses
11930900000 USD
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
232800000 USD
CY2019 sbux Store Operating Expenses
StoreOperatingExpenses
10493600000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1338200000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1084700000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
253500000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1307900000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
850800000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
457100000 USD
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
223400000 USD
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
223700000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
194300000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
21000000.0 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
20400000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
14400000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1400000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
2000000.0 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
253500000 USD
CY2019Q3 us-gaap Goodwill
Goodwill
3490800000 USD
CY2020 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
106400000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
3597200000 USD
CY2021 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
80100000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
3677300000 USD
CY2021Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
16014100000 USD
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
14713800000 USD
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
16006400000 USD
CY2020Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
17498700000 USD
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
119700000 USD
CY2020Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
132500000 USD
CY2021Q4 us-gaap Hedging Liabilities Noncurrent
HedgingLiabilitiesNoncurrent
21700000 USD
CY2020Q3 us-gaap Hedging Liabilities Noncurrent
HedgingLiabilitiesNoncurrent
35600000 USD
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
14615800000 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
15909500000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1000000000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1000000000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1513800000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1250000000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
500000000.0 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
9450000000 USD
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
14713800000 USD
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
1579200000 USD
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
1573600000 USD
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
949600000 USD
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
833400000 USD
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
30900000 USD
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
34100000 USD
CY2021 us-gaap Lease Cost
LeaseCost
2559700000 USD
CY2020 us-gaap Lease Cost
LeaseCost
2441100000 USD
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
1707100000 USD
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
1463300000 USD
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1590300000 USD
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1093000000 USD
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y8M12D
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y9M18D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.025
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.025
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1504600000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1441300000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1310200000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1156600000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1012500000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3704700000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
10129900000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1140600000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
8989300000 USD
CY2021Q4 sbux Lessee Operating Lease Lease Not Yet Commenced Amount
LesseeOperatingLeaseLeaseNotYetCommencedAmount
830900000 USD
CY2019 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
1441700000 USD
CY2019 us-gaap Operating Leases Rent Expense Contingent Rentals
OperatingLeasesRentExpenseContingentRentals
224300000 USD
CY2019 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1666000000 USD
CY2019 us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
10900000 USD
CY2018Q3 sbux Prepaid Royalty Economic Life
PrepaidRoyaltyEconomicLife
P40Y
CY2018Q3 us-gaap Deferred Revenue
DeferredRevenue
7000000000 USD
CY2021 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
176600000 USD
CY2020 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
176800000 USD
CY2019 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
175200000 USD
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2400000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7500000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
139600000 shares
CY2019 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10100000000 USD
CY2020Q3 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
48900000 shares
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.49
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
319100000 USD
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
248500000 USD
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
308000000.0 USD
CY2021 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
51600000 USD
CY2020 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
47800000 USD
CY2019 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
59300000 USD
CY2021 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
3700000 USD
CY2020 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
3600000 USD
CY2019 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
3400000 USD
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P8Y1M6D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y9M18D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y1M6D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.263
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.273
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.216
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.014
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.012
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.029
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.016
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.029
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.021
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
110.46
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
56.33
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
67.33
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
27.59
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.30
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.06
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9200000 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
53.06
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y4M24D
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
286000000 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0.0 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
110.46
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
4000000.0 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
51.31
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
-0.0 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
56.69
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5200000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
54.58
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y6M
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
303000000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4400000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
53.06
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y1M6D
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
261000000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
5200000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
54.57
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y6M
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
302000000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
0.10
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.95
CY2021 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
500000 shares
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
145100000 USD
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
132700000 USD
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
122100000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
4138500000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
904600000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
3518700000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
1218400000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
259800000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
947500000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5356900000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1164400000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4466200000 USD
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-8400000 USD
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
681800000 USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
49900000 USD
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1414300000 USD
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
190000000.0 USD
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
36900000 USD
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
447800000 USD
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
409800000 USD
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
181400000 USD
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
458300000 USD
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1281600000 USD
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
268200000 USD
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2320400000 USD
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
10400000 USD
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1074500000 USD
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-6400000 USD
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-4800000 USD
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-322400000 USD
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-129000000.0 USD
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-15300000 USD
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-51900000 USD
CY2021 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-125000000.0 USD
CY2020 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-28500000 USD
CY2019 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1448800000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1156600000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
239700000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
871600000 USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.027
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.022
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.021
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.005
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.032
CY2019 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.001
CY2021 sbux Effective Income Tax Rate Reconciliation Valuation Allowance Percent
EffectiveIncomeTaxRateReconciliationValuationAllowancePercent
-0.013
CY2020 sbux Effective Income Tax Rate Reconciliation Valuation Allowance Percent
EffectiveIncomeTaxRateReconciliationValuationAllowancePercent
-0.022
CY2019 sbux Effective Income Tax Rate Reconciliation Valuation Allowance Percent
EffectiveIncomeTaxRateReconciliationValuationAllowancePercent
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.009
CY2020 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.042
CY2019 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.021
CY2021 sbux Effective Income Tax Rate Reconciliation Tax Rate Change Percent
EffectiveIncomeTaxRateReconciliationTaxRateChangePercent
-0.005
CY2020 sbux Effective Income Tax Rate Reconciliation Tax Rate Change Percent
EffectiveIncomeTaxRateReconciliationTaxRateChangePercent
-0.014
CY2019 sbux Effective Income Tax Rate Reconciliation Tax Rate Change Percent
EffectiveIncomeTaxRateReconciliationTaxRateChangePercent
-0.015
CY2021 sbux Income Tax Rate Reconciliation Charitable Contributions Percent
IncomeTaxRateReconciliationCharitableContributionsPercent
-0.004
CY2020 sbux Income Tax Rate Reconciliation Charitable Contributions Percent
IncomeTaxRateReconciliationCharitableContributionsPercent
-0.017
CY2019 sbux Income Tax Rate Reconciliation Charitable Contributions Percent
IncomeTaxRateReconciliationCharitableContributionsPercent
0
CY2021 sbux Effective Income Tax Rate Reconciliation Foreign Derived Intangible Income Percent
EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent
0.002
CY2020 sbux Effective Income Tax Rate Reconciliation Foreign Derived Intangible Income Percent
EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent
0.100
CY2019 sbux Effective Income Tax Rate Reconciliation Foreign Derived Intangible Income Percent
EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomePercent
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings
EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings
EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings
EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
0.017
CY2021 us-gaap Effective Income Tax Rate Reconciliation Disposition Of Business
EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation Disposition Of Business
EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation Disposition Of Business
EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
-0.013
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.003
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.001
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.003
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.216
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.206
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.195
CY2021Q4 sbux Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
2395200000 USD
CY2020Q3 sbux Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
2313000000 USD
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
1679400000 USD
CY2020Q3 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
1678600000 USD
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
317700000 USD
CY2020Q3 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
248600000 USD
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
641000000.0 USD
CY2020Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
554400000 USD
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5033300000 USD
CY2020Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4794600000 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
275300000 USD
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
239400000 USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4758000000 USD
CY2020Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4555200000 USD
CY2021Q4 sbux Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
-2296500000 USD
CY2020Q3 sbux Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
-2191800000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
451200000 USD
CY2020Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
463300000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
284000000.0 USD
CY2020Q3 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
268300000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3031700000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2923400000 USD
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1726300000 USD
CY2020Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1631800000 USD
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
1874800000 USD
CY2020Q3 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
1789900000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
148500000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
158100000 USD
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1726300000 USD
CY2020Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1631800000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
82600000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
62800000 USD
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
4600000 USD
CY2020 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
-3000000 USD
CY2019 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
2800000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
7100000 USD
CY2020Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
13000000 USD
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
123700000 USD
CY2019Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
132100000 USD
CY2018Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
224600000 USD
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
4800000 USD
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
11100000 USD
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
3800000 USD
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
11900000 USD
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
500000 USD
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
75300000 USD
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
8900000 USD
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
9800000 USD
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
18500000 USD
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
4400000 USD
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0 USD
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
16400000 USD
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
38500000 USD
CY2020 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
28800000 USD
CY2019 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
23100000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
82600000 USD
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
123700000 USD
CY2019Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
132100000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
4199300000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
928300000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
3599200000 USD
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1177600000 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1172800000 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1221200000 shares
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
7900000 shares
CY2020 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
9000000.0 shares
CY2019 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
12000000.0 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1185500000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1181800000 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1233200000 shares
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.57
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.79
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.95
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.54
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.79
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.92
CY2021 us-gaap Factors Used To Identify Entitys Reportable Segments
FactorsUsedToIdentifyEntitysReportableSegments
Segment information is prepared on the same basis that our ceo, who is our Chief Operating Decision Maker, manages the segments, evaluates financial results and makes key operating decisions.
CY2021 us-gaap Revenues
Revenues
29060600000 USD
CY2020 us-gaap Revenues
Revenues
23518000000 USD
CY2019 us-gaap Revenues
Revenues
26508600000 USD
CY2021 us-gaap Revenues
Revenues
29060600000 USD
CY2020 us-gaap Revenues
Revenues
23518000000 USD
CY2019 us-gaap Revenues
Revenues
26508600000 USD
CY2021Q4 us-gaap Noncurrent Assets
NoncurrentAssets
21636200000 USD
CY2020Q3 us-gaap Noncurrent Assets
NoncurrentAssets
21568100000 USD
CY2019Q3 us-gaap Noncurrent Assets
NoncurrentAssets
13565700000 USD
CY2021 us-gaap Segment Reporting Disclosure Of Major Customers
SegmentReportingDisclosureOfMajorCustomers
No customer accounts for 10% or more of our revenues
CY2021 us-gaap Revenues
Revenues
29060600000 USD
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1441700000 USD
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
385300000 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
4872100000 USD
CY2021Q4 us-gaap Assets
Assets
31392600000 USD
CY2020 us-gaap Revenues
Revenues
23518000000 USD
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1431300000 USD
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
322500000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
1561700000 USD
CY2020Q3 us-gaap Assets
Assets
29374500000 USD
CY2019 us-gaap Revenues
Revenues
26508600000 USD
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1377300000 USD
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
298000000.0 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
4077900000 USD
CY2019Q3 us-gaap Assets
Assets
19219600000 USD

Files In Submission

Name View Source Status
0000829224-21-000086-index-headers.html Edgar Link pending
0000829224-21-000086-index.html Edgar Link pending
0000829224-21-000086.txt Edgar Link pending
0000829224-21-000086-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
report.css Edgar Link pending
sbux-1032021xexhibit21.htm Edgar Link pending
sbux-1032021xexhibit23.htm Edgar Link pending
sbux-1032021xexhibit311.htm Edgar Link pending
sbux-1032021xexhibit312.htm Edgar Link pending
sbux-1032021xexhibit32.htm Edgar Link pending
sbux-20211003.htm Edgar Link pending
sbux-20211003.xsd Edgar Link pending
sbux-20211003_cal.xml Edgar Link unprocessable
sbux-20211003_def.xml Edgar Link unprocessable
sbux-20211003_g1.jpg Edgar Link pending
sbux-20211003_g2.jpg Edgar Link pending
sbux-20211003_htm.xml Edgar Link completed
sbux-20211003_lab.xml Edgar Link unprocessable
sbux-20211003_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending